Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition (TB-Speed SAM)

NCT ID: NCT04240990

Last Updated: 2025-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

603 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-04

Study Completion Date

2022-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

TB-Speed SAM is a multicentric, prospective diagnostic cohort study conducted in two countries with high and very high TB incidence (Uganda and Zambia). It aims at assessing several diagnostic tests that could result in the development of a score and algorithm for TB treatment decision in hospitalised children with severe acute malnutrition (SAM).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is now strong evidence that undiagnosed and untreated TB increases the risk of death in children, especially those severely malnourished who are highly vulnerable. Specific decision-making tools are therefore urgently needed to guide clinicians from high TB burden and low-income countries to initiate treatment quickly in children with SAM with suspected TB.

A diagnostic prediction score and algorithm was recently proposed by the investigators for TB treatment decision in HIV-infected children with presumptive TB (developed in the ANRS 12229 PAANTHER 01 study). Based on easily collected clinical features, chest X-Ray (CXR), Xpert MTB/RIF, and abdominal ultrasonography, the score aims to help clinicians make a same-day treatment decision. Such a prediction score improving TB diagnosis and shortening time to treatment initiation would be a key benefit in children with SAM.

Based on this experience, the investigators are proposing a diagnostic cohort study enrolling hospitalized severely malnourished children. The study will include the evaluation of several diagnostic tests that could be integrated in the development of a prediction model and subsequent score for the diagnosis of TB in hospitalized children with SAM. This will include Xpert MTB/RIF Ultra performed on one nasopharyngeal aspirate (NPA) and one stool sample, CXR, Quantiferon (QFT) Interferon-Gamma Release Assay (IGRA), Monocyte-to-lymphocyte ratio (MLR), and ultrasonography, which has shown its interest for the diagnosis of TB in both HIV-infected adults and children. In the PAANTHER study, it detected abdominal lymphadenopathy in 50% of culture confirmed TB cases and 35% of all confirmed and unconfirmed cases, with a specificity of 85%.

Using logistic regression, a score will be developed for TB diagnosis, considering confirmed and unconfirmed TB as reference diagnosis, in hospitalized children with SAM. As a secondary objective, and in order to reduce costs, sample collection, and complexity of the diagnostic process, a first-step screening score (excluding Ultra, abdominal ultrasound, and CXR if possible) will be developed to identify children with presumptive TB who would benefit from further diagnostic testing.

Both scores will be internally validated using resampling and will be incorporated in a stepwise algorithm to guide practical implementation of the screening and diagnosis process. The stepwise algorithm will be discussed with local clinicians involved in the study to better adapt it for future use in their routine practice.

The study will be implemented at inpatient nutrition centres from three selected tertiary hospitals in Uganda, and Zambia. A total of 720 children \<5 years old with WHO-defined severe acute malnutrition will be enrolled, that is approximately 240 participants per hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tuberculosis Severe Acute Malnutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

TB-Speed SAM is a multicentric, prospective diagnostic cohort study assessing several diagnostic tests that could result in the development of a score and algorithm for TB treatment decision in hospitalised children with SAM.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prospective cohort

Children included in the cohort will all be in the same arm. The patients will benefit from standard-of-care TB diagnosis with additional diagnostic methods.

Group Type EXPERIMENTAL

Development of a score and algorithm for TB treatment decision in hospitalised children with SAM.

Intervention Type OTHER

The diagnostic strategy will include an initial clinical, radiographic and bacteriological evaluation of all enrolled children:

* TB contact history
* Suggestive TB symptoms in the previous 4 weeks
* Physical examination
* Clinical, anthropometric and biochemical assessment of malnutrition
* Clinical assessment for other non-dietary causes of malnutrition
* Digitalized CXR
* Ultra performed on NPA and stool samples, and one gastric aspirate (GA)
* Mycobacterial culture performed on two GAs
* Abdominal ultrasonography
* QuantiFERON®-TB Gold IGRA
* Monocyte-to-Lymphocyte Ratio (MLR)
* C-Reactive Protein (CRP)

TB diagnosis will be made according to national TB guidelines.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Development of a score and algorithm for TB treatment decision in hospitalised children with SAM.

The diagnostic strategy will include an initial clinical, radiographic and bacteriological evaluation of all enrolled children:

* TB contact history
* Suggestive TB symptoms in the previous 4 weeks
* Physical examination
* Clinical, anthropometric and biochemical assessment of malnutrition
* Clinical assessment for other non-dietary causes of malnutrition
* Digitalized CXR
* Ultra performed on NPA and stool samples, and one gastric aspirate (GA)
* Mycobacterial culture performed on two GAs
* Abdominal ultrasonography
* QuantiFERON®-TB Gold IGRA
* Monocyte-to-Lymphocyte Ratio (MLR)
* C-Reactive Protein (CRP)

TB diagnosis will be made according to national TB guidelines.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children aged 2 to 59 months
* Severe acute malnutrition defined as weight-for-height Z score (WHZ) \< -3 standard deviation (SD) or mid-upper arm circumference (MUAC) \< 115 mm (in children over 6 months) or clinical signs of bilateral pitting oedema
* Hospitalized per hospital clinician's decision
* Parent/guardian informed consent

Exclusion Criteria

\- Ongoing TB treatment or history of intake of anti-TB drugs in the last 3 months
Minimum Eligible Age

2 Months

Maximum Eligible Age

59 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

UNITAID

OTHER

Sponsor Role collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier Marcy, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Bordeaux, France

Maryline Bonnet, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Institut de Recherche pour le Développemnt (IRD) Montpellier, France

Eric Wobudeya, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

MU-JHU Care Ltd, Kampala, Uganda

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mulago National Referral Hospital

Kampala, , Uganda

Site Status

Lusaka University Teaching Hospital

Lusaka, , Zambia

Site Status

Arthur Davidson Children Hospital

Ndola, , Zambia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Uganda Zambia

References

Explore related publications, articles, or registry entries linked to this study.

Chabala C, Roucher C, Ton Nu Nguyet MH, Babirekere E, Inambao M, Businge G, Kapula C, Shankalala P, Nduna B, Mulenga V, Graham S, Wobudeya E, Bonnet M, Marcy O; TB-Speed SAM study group. Development of tuberculosis treatment decision algorithms in children below 5 years hospitalised with severe acute malnutrition in Zambia and Uganda: a prospective diagnostic cohort study. EClinicalMedicine. 2024 Jun 20;73:102688. doi: 10.1016/j.eclinm.2024.102688. eCollection 2024 Jul.

Reference Type RESULT
PMID: 39007063 (View on PubMed)

d'Elbee M, Mafirakureva N, Chabala C, Huyen Ton Nu Nguyet M, Harker M, Roucher C, Businge G, Shankalala P, Nduna B, Mulenga V, Bonnet M, Wobudeya E, Marcy O, Dodd PJ. Treatment decision algorithms for tuberculosis screening and diagnosis in children below 5 years hospitalised with severe acute malnutrition: a cost-effectiveness analysis. EClinicalMedicine. 2025 Apr 19;83:103206. doi: 10.1016/j.eclinm.2025.103206. eCollection 2025 May.

Reference Type RESULT
PMID: 40291345 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.tb-speed.com

TB-Speed project official website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C18-28

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TB Screening Improves Preventive Therapy Uptake
NCT04557176 ACTIVE_NOT_RECRUITING NA